# Inland Real Estate Income Trust, Inc.: financial statements, quarterly

INRE · OTC · CIK 1528985 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inre.md) · [Financials](/companies/inre/financials.md) · [Filings](/companies/inre/filings.md) · [Insiders](/companies/inre/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/inre/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [36.4](/filings/0000950170-24-123135.md) | [38.5 d](/filings/0001528985-26-000002.md) | [37.5](/filings/0000950170-25-065772.md) | [37.5](/filings/0000950170-25-107168.md) | [37.3](/filings/0001193125-25-268836.md) | [37.9 d](/filings/0001528985-26-000002.md) | [38.8](/filings/0001528985-26-000004.md) | [38.1](/filings/0001528985-26-000007.md) | [38.0](/filings/0001193125-25-268836.md) | [38.7 d](/filings/0001528985-26-000002.md) | [38.9](/filings/0001528985-26-000004.md) | [37.8](/filings/0001528985-26-000007.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [10.7](/filings/0000950170-24-123135.md) | [10.5 d](/filings/0001528985-26-000002.md) | [10.4](/filings/0000950170-25-065772.md) | [10.4](/filings/0000950170-25-107168.md) | [10.4](/filings/0001193125-25-268836.md) | [10.1 d](/filings/0001528985-26-000002.md) | [9.7](/filings/0001528985-26-000004.md) | [9.8](/filings/0001528985-26-000007.md) | [9.8](/filings/0001193125-25-268836.md) | [9.8 d](/filings/0001528985-26-000002.md) | [9.9](/filings/0001528985-26-000004.md) | [10.0](/filings/0001528985-26-000007.md) |
| Net income | $m | [(3.7)](/filings/0000950170-24-123135.md) | [(3.8) d](/filings/0001528985-26-000002.md) | [(3.3)](/filings/0000950170-25-065772.md) | [(3.2)](/filings/0000950170-25-107168.md) | [(3.2)](/filings/0001193125-25-268836.md) | [(5.2) d](/filings/0001528985-26-000002.md) | [(2.6)](/filings/0001528985-26-000004.md) | [(2.2)](/filings/0001528985-26-000007.md) | [(2.0)](/filings/0001193125-25-268836.md) | [(4.3) d](/filings/0001528985-26-000002.md) | [(2.2)](/filings/0001528985-26-000004.md) | [1.1](/filings/0001528985-26-000007.md) |
| Diluted EPS | $ per share | [(0.10)](/filings/0000950170-24-123135.md) | not reported | [(0.09)](/filings/0000950170-25-065772.md) | [(0.09)](/filings/0000950170-25-107168.md) | [(0.09)](/filings/0001193125-25-268836.md) | not reported | [(0.07)](/filings/0001528985-26-000004.md) | [(0.06)](/filings/0001528985-26-000007.md) | [(0.05)](/filings/0001193125-25-268836.md) | not reported | [(0.06)](/filings/0001528985-26-000004.md) | [0.03](/filings/0001528985-26-000007.md) |
| Basic EPS | $ per share | [(0.10)](/filings/0000950170-24-123135.md) | not reported | [(0.09)](/filings/0000950170-25-065772.md) | [(0.09)](/filings/0000950170-25-107168.md) | [(0.09)](/filings/0001193125-25-268836.md) | not reported | [(0.07)](/filings/0001528985-26-000004.md) | [(0.06)](/filings/0001528985-26-000007.md) | [(0.05)](/filings/0001193125-25-268836.md) | not reported | [(0.06)](/filings/0001528985-26-000004.md) | [0.03](/filings/0001528985-26-000007.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.3](/filings/0000950170-24-123135.md) | [6.0](/filings/0000950170-25-033568.md) | [7.7](/filings/0000950170-25-065772.md) | [10.7](/filings/0000950170-25-107168.md) | [10.9](/filings/0001193125-25-268836.md) | [6.4](/filings/0001528985-26-000002.md) | [8.1](/filings/0001528985-26-000004.md) | [12.0](/filings/0001528985-26-000007.md) | [11.5](/filings/0001193125-25-268836.md) | [8.0](/filings/0001528985-26-000007.md) | [9.2](/filings/0001528985-26-000004.md) | [10.8](/filings/0001528985-26-000007.md) |
| Total assets | $m | [1,370](/filings/0000950170-23-061064.md) | [1,344](/filings/0000950170-25-033568.md) | [1,338](/filings/0000950170-24-055382.md) | [1,327](/filings/0000950170-24-095966.md) | [1,303](/filings/0000950170-24-123135.md) | [1,295](/filings/0001528985-26-000002.md) | [1,277](/filings/0000950170-25-065772.md) | [1,266](/filings/0000950170-25-107168.md) | [1,255](/filings/0001193125-25-268836.md) | [1,248](/filings/0001528985-26-000007.md) | [1,239](/filings/0001528985-26-000004.md) | [1,207](/filings/0001528985-26-000007.md) |
| Total liabilities | $m | [938](/filings/0000950170-23-061064.md) | [936](/filings/0000950170-25-033568.md) | [932](/filings/0000950170-24-055382.md) | [930](/filings/0000950170-24-095966.md) | [929](/filings/0000950170-24-123135.md) | [925](/filings/0001528985-26-000002.md) | [921](/filings/0000950170-25-065772.md) | [920](/filings/0000950170-25-107168.md) | [918](/filings/0001193125-25-268836.md) | [923](/filings/0001528985-26-000007.md) | [919](/filings/0001528985-26-000004.md) | [889](/filings/0001528985-26-000007.md) |
| Long-term debt | $m | [844](/filings/0000950170-23-061064.md) | [844](/filings/0000950170-25-033568.md) | [842](/filings/0000950170-24-055382.md) | [840](/filings/0000950170-24-095966.md) | [836](/filings/0000950170-24-123135.md) | [836](/filings/0001528985-26-000002.md) | [836](/filings/0000950170-25-065772.md) | [833](/filings/0000950170-25-107168.md) | [829](/filings/0001193125-25-268836.md) | [837](/filings/0001528985-26-000007.md) | [836](/filings/0001528985-26-000004.md) | [806](/filings/0001528985-26-000007.md) |
| Shareholders' equity | $m | [432](/filings/0000950170-24-123135.md) | [408](/filings/0001528985-26-000002.md) | [406](/filings/0000950170-25-107168.md) | [397](/filings/0001193125-25-268836.md) | [374](/filings/0001193125-25-268836.md) | [369](/filings/0001528985-26-000007.md) | [357](/filings/0001528985-26-000007.md) | [346](/filings/0001528985-26-000007.md) | [337](/filings/0001193125-25-268836.md) | [325](/filings/0001528985-26-000007.md) | [320](/filings/0001528985-26-000007.md) | [318](/filings/0001528985-26-000007.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [9.4 d](/filings/0000950170-24-123135.md) | [5.0 d](/filings/0001528985-26-000002.md) | [11.9](/filings/0000950170-25-065772.md) | [13.9 d](/filings/0000950170-25-107168.md) | [13.2 d](/filings/0001193125-25-268836.md) | [4.3 d](/filings/0001528985-26-000002.md) | [11.8](/filings/0001528985-26-000004.md) | [14.8 d](/filings/0001528985-26-000007.md) | [12.6 d](/filings/0001193125-25-268836.md) | [3.5 d](/filings/0001528985-26-000002.md) | [10.8](/filings/0001528985-26-000004.md) | [13.8 d](/filings/0001528985-26-000007.md) |
| Dividends paid | $m | [4.9](/filings/0000950170-24-123135.md) | [4.9 d](/filings/0001528985-26-000002.md) | [4.9](/filings/0000950170-25-065772.md) | [4.9](/filings/0000950170-25-107168.md) | [4.9](/filings/0001193125-25-268836.md) | [4.9 d](/filings/0001528985-26-000002.md) | [4.9](/filings/0001528985-26-000004.md) | [4.9](/filings/0001528985-26-000007.md) | [4.9](/filings/0001193125-25-268836.md) | [4.9 d](/filings/0001528985-26-000002.md) | [4.9](/filings/0001528985-26-000004.md) | [4.9](/filings/0001528985-26-000007.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [36.2](/filings/0000950170-23-061064.md) | [36.2](/filings/0000950170-24-055382.md) | [36.2](/filings/0000950170-24-095966.md) | [36.2](/filings/0000950170-24-123135.md) | [36.2](/filings/0000950170-25-065772.md) | [36.1](/filings/0000950170-25-107168.md) | [36.1](/filings/0001193125-25-268836.md) | [36.1](/filings/0001528985-26-000004.md) | [36.1](/filings/0001528985-26-000007.md) | [36.1](/filings/0001193125-25-268836.md) | [36.1](/filings/0001528985-26-000004.md) | [36.1](/filings/0001528985-26-000007.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,012,053 at 2026-08-04, from the cover of the [10-Q filed 2026-08-05](/filings/0001528985-26-000007.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.